Skip to main content
. 2012 Jun 1;26(11):1247–1262. doi: 10.1101/gad.193565.112

Figure 8.

Figure 8.

PDGFRβ promotes GSC in vivo tumor propagation. (A) The median survival and number of tumors formed are shown for 08-387 and 08-322 GSCs expressing nontargeting shRNA (shNT) or shRNA directed against PDGFRβ (shPDGFRβ I and shPDGFRβ II). Kaplan-Meier survival curves for 08-387 (B) and 08-322 (C) GSCs expressing nontargeting shRNA (shNT) or shPDGFRβ demonstrate delayed tumor growth with shPDGFRβ.